BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24106770)

  • 1. "Unique trend" and "contradictory trend" in discrimination of primary synchronous lung cancer and metastatic lung cancer.
    Shen C; Xu H; Liu L; Zhou Y; Chen D; Du H; Han Z; Che G
    BMC Cancer; 2013 Oct; 13():467. PubMed ID: 24106770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Different trend" in multiple primary lung cancer and intrapulmonary metastasis.
    Shen C; Wang X; Tian L; Zhou Y; Chen D; Du H; Wang W; Liu L; Che G
    Eur J Med Res; 2015 Feb; 20(1):17. PubMed ID: 25889108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
    Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
    Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.
    Ono K; Sugio K; Uramoto H; Baba T; Ichiki Y; Takenoyama M; Hanagiri T; Oyama T; Yasumoto K
    Cancer; 2009 Aug; 115(15):3489-500. PubMed ID: 19452548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.
    Goto T; Hirotsu Y; Mochizuki H; Nakagomi T; Shikata D; Yokoyama Y; Oyama T; Amemiya K; Okimoto K; Omata M
    Oncotarget; 2017 May; 8(19):31133-31143. PubMed ID: 28415711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis].
    Wang J; Lu C; Liu XY; Zhang HB; Zhao J; Yang L; Guo QZ; An TT; Wu MN
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):103-7. PubMed ID: 17445470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
    J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
    Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite analysis for differentiating the origin of renal angiomyolipoma and involved regional lymph node.
    Tan P; Xu H; Jiang Y; Yang L; Zou Y; Liu L; Liu N; Cao D; Fan Y; Li Q; Wei Q
    Sci Rep; 2017 Mar; 7(1):362. PubMed ID: 28336972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
    Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
    Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.
    Nonami Y; Ohtuki Y; Sasaguri S
    J Cardiovasc Surg (Torino); 2003 Oct; 44(5):661-5. PubMed ID: 14735056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis.
    Zhou X; Tian L; Fan J; Lai Y; Li S; Che G; Huang J
    Medicine (Baltimore); 2016 Aug; 95(31):e4478. PubMed ID: 27495091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous primary lung cancers: a multidisciplinary approach in diagnosis.
    Kontic M; Stevic R; Stojsic J; Jekic B; Bunjevacki V
    Tumori; 2011; 97(4):e16-9. PubMed ID: 21989450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hMLH1 methylation in the development of synchronous sporadic colorectal carcinomas.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    Dis Colon Rectum; 2002 May; 45(5):674-80. PubMed ID: 12004219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
    Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
    J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent microsatellite instability in synchronous ovarian and endometrial adenocarcinoma and its usefulness for differential diagnosis.
    Kaneki E; Oda Y; Ohishi Y; Tamiya S; Oda S; Hirakawa T; Nakano H; Tsuneyoshi M
    Hum Pathol; 2004 Dec; 35(12):1484-93. PubMed ID: 15619207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for common clonal origin of multifocal lung cancers.
    Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
    J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous lung cancers defined by deoxyribonucleic acid flow cytometry.
    Ichinose Y; Hara N; Ohta M
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):418-24. PubMed ID: 1652669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing multiple lung primaries from intra-pulmonary metastases and treatment implications.
    Voulaz E; Novellis P; Rossetti F; Solinas M; Rossi S; Alloisio M; Pelosi G; Veronesi G
    Expert Rev Anticancer Ther; 2020 Nov; 20(11):985-995. PubMed ID: 32915097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.